PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
08-Nov-2023 Protein Expression Technology Market growth, fueled by innovations in protein discovery, is forecasted to reach US$ 4,774.80 Million by 2033, according to FMI MARKITWIRED
08-Nov-2023 Pneumonia Diagnostics Market is gaining ground with an estimated valuation of US$ 899.4 Million by 2032 | FMI MARKITWIRED
08-Nov-2023 Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension Businesswire
08-Nov-2023 Medical Clothing Market Updates : Projected to Cross USD 96.4 Billion by 2031, CAGR of 8.4% from 2022 to 2031 The Wire Times
08-Nov-2023 Teva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients Business Businesswire
08-Nov-2023 Evolus Reports Record Third Quarter 2023 Financial Results and Phase II Data for Extra-Strength 40U Formulation of Jeuveau® Businesswire
08-Nov-2023 Electromed, Inc. Announces Fiscal 2024 First Quarter Financial Results Businesswire
08-Nov-2023 VTEX Reports Third Quarter 2023 Financial Results Businesswire
08-Nov-2023 Arcus Biosciences Reports Third Quarter 2023 Financial Results and Provides a Pipeline Update Businesswire
08-Nov-2023  Biodesix Announces Third Quarter 2023 Results and Highlights Businesswire
08-Nov-2023 Xencor Reports Third Quarter 2023 Financial Results Businesswire
08-Nov-2023 Establishment Labs Reports Third Quarter 2023 Financial Results Businesswire
07-Nov-2023 New Research Shows High Accuracy of Precivity™ Blood Biomarkers in the Evaluation of Brain Amyloid in Pre-Clinical Alzheimer's Disease Businesswire
07-Nov-2023 North America Dominates the Solvent Evaporation Market with Technological Innovations | CAGR 5.8% The Wire Times
07-Nov-2023 Aelis Farma Announces Positive Results of Non-clinical Studies Required by Regulatory Agencies to Enter Its First CB1-SSi, AEF0117, in Phase 3 Clinical Trial for the Treatment of Cannabis Use Disorder Businesswire
07-Nov-2023 Marinus Pharmaceuticals inicia programa de acesso mundial para CV de suspensão oral do ZTALMY® (ganaxolona) Businesswire
07-Nov-2023 Marinus Pharmaceuticals inicia un programa de acceso global para ZTALMY® (ganaxolona) en suspensión oral CV Businesswire
07-Nov-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Outlook Therapeutics, Inc. (OTLK) on Behalf of Investors Businesswire
07-Nov-2023 Marinus Pharmaceuticals inicia un programa de acceso global para ZTALMY® (ganaxolona) en suspensión oral CV Businesswire
07-Nov-2023 Transgene Reports Business Update and Q3 2023 Financial Position Businesswire